Gastrointestinal Therapeutics Market Share

Statistics for the 2023 & 2024 Gastrointestinal Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Gastrointestinal Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Gastrointestinal Therapeutics Industry

The gastrointestinal therapeutics market is moderately competitive, with the presence of many market players. The companies are adopting key strategies such as new product development, collaborations, partnerships, and others to retain their market position. Some market players include Abbvie Inc., AstraZeneca, Johnson & Johnson (Janssen Global Services LLC), Takeda Pharmaceutical Company Limited, and Bausch Health Companies Inc. (Salix Pharmaceuticals Inc.).

Gastrointestinal Therapeutics Market Leaders

  1. Abbvie Inc.

  2. AstraZeneca

  3. Takeda Pharmaceutical Company Limited

  4. Bausch Health Companies Inc. (Salix Pharmaceuticals Inc.)

  5. Johnson & Johnson(Janssen Global Services LLC)

*Disclaimer: Major Players sorted in no particular order

Gastrointestinal Therapeutics Market Concentration

Gastrointestinal Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)